Listed on Euronext Paris

IPO on 24 October 1997
ISIN code: FR0014000MR3
Ticker codes: Reuters EUFI.PA, Bloomberg ERF FP

Index membership

Euronext Paris

CAC 40, EURONEXT 100, SBF 120, SBF TOP 80 EW, CAC ALL SHARES, CAC ALL-TRADABLE, CAC HEALTH CARE, CAC LARGE 60.

Euronext Amsterdam

EN EUR N100 EW, EN EUROZONE 150 EW, EN EUROPE 500, EN EUROZONE 300, EN EZ 100 ESG.

Other

MSCI Europe, STOXX Europe 600, S&P Europe 350

Industry classification

GICS Sector

Healthcare

GICS Industry

Life Sciences Tools & Services

Dividend

Gross dividend of EUR 0.60 per share for the financial year ended 31 December 2024.

EX date

28/04/2025

Record date

29/04/2025

Pay date

30/04/2025

Share price development

Since its IPO in 1997, Eurofins has been one of the best performing shares in Europe, with a CAGR (Compound Annual Growth Rate) of its share price of 23% between its IPO on 24 October 1997 at €0.183 and 31 December 2024 at €49.31.

Ownership structure

Free float
Martin family

More information on the ownership structure can be found in Eurofins’ most recent Annual and Half-year Reports.

Shares in issue

Analyst coverage

Eurofins Scientific S.E. is covered by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Eurofins’ performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Eurofins or its management.

Eurofins does not by its reference or distribution imply its endorsement of or concurrence with such information, conclusions, or recommendations.

Expand_img
AlphaValue Nupur Gupta
Barclays James Rose
Berenberg Carl Raynsford
BernsteinSG Delphine Le Louet
CIC Market Solutions Arnaud Cadart
Citi Arthur Truslove
Deutsche Bank Ben Wild
BNP Paribas Exane Tom Burlton
Gilbert Dupont Guillaume Cuvillier
Goldman Sachs Suhasini Varanasi
Jefferies Allen Wells
Kepler Cheuvreux Pablo Cuadrado
Morgan Stanley Remi Grenu
Morningstar Jay Lee
ODDO BHF Geoffroy Michalet
Redburn Neil Tyler